0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global AI Drug Development Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-29Q5733
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global AI Drug Development Market Insights Forecast to 2028
BUY CHAPTERS

Global AI Drug Development Market Research Report 2025

Code: QYRE-Auto-29Q5733
Report
July 2025
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

AI Drug Development Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

AI Drug Development Market

AI Drug Development Market

The global market for AI Drug Development was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for AI Drug Development, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI Drug Development.
The AI Drug Development market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global AI Drug Development market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the AI Drug Development companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of AI Drug Development Market Report

Report Metric Details
Report Name AI Drug Development Market
CAGR 5%
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Insilico Medicine, Cyclica, XtalPi Inc., Exscientia Limited, AiCure, LLC, Atomwise, Biovista Inc., Breg,Inc., Numerate, Cloud Pharmaceuticals, IBM, NuMedii, BenevolentAI, Lam Therapeutics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of AI Drug Development company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the AI Drug Development Market report?

Ans: The main players in the AI Drug Development Market are Insilico Medicine, Cyclica, XtalPi Inc., Exscientia Limited, AiCure, LLC, Atomwise, Biovista Inc., Breg,Inc., Numerate, Cloud Pharmaceuticals, IBM, NuMedii, BenevolentAI, Lam Therapeutics

What are the Application segmentation covered in the AI Drug Development Market report?

Ans: The Applications covered in the AI Drug Development Market report are Tumor, Nervous System, Other

What are the Type segmentation covered in the AI Drug Development Market report?

Ans: The Types covered in the AI Drug Development Market report are Drug Design, Drug Synthesis, Other

Recommended Reports

AI Drug Platforms

Drug Testing Diagnostics

Drug Development & Safety

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AI Drug Development Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Drug Design
1.2.3 Drug Synthesis
1.2.4 Other
1.3 Market by Application
1.3.1 Global AI Drug Development Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Tumor
1.3.3 Nervous System
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global AI Drug Development Market Perspective (2020-2031)
2.2 Global AI Drug Development Growth Trends by Region
2.2.1 Global AI Drug Development Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 AI Drug Development Historic Market Size by Region (2020-2025)
2.2.3 AI Drug Development Forecasted Market Size by Region (2026-2031)
2.3 AI Drug Development Market Dynamics
2.3.1 AI Drug Development Industry Trends
2.3.2 AI Drug Development Market Drivers
2.3.3 AI Drug Development Market Challenges
2.3.4 AI Drug Development Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AI Drug Development Players by Revenue
3.1.1 Global Top AI Drug Development Players by Revenue (2020-2025)
3.1.2 Global AI Drug Development Revenue Market Share by Players (2020-2025)
3.2 Global AI Drug Development Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by AI Drug Development Revenue
3.4 Global AI Drug Development Market Concentration Ratio
3.4.1 Global AI Drug Development Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AI Drug Development Revenue in 2024
3.5 Global Key Players of AI Drug Development Head office and Area Served
3.6 Global Key Players of AI Drug Development, Product and Application
3.7 Global Key Players of AI Drug Development, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 AI Drug Development Breakdown Data by Type
4.1 Global AI Drug Development Historic Market Size by Type (2020-2025)
4.2 Global AI Drug Development Forecasted Market Size by Type (2026-2031)
5 AI Drug Development Breakdown Data by Application
5.1 Global AI Drug Development Historic Market Size by Application (2020-2025)
5.2 Global AI Drug Development Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America AI Drug Development Market Size (2020-2031)
6.2 North America AI Drug Development Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America AI Drug Development Market Size by Country (2020-2025)
6.4 North America AI Drug Development Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AI Drug Development Market Size (2020-2031)
7.2 Europe AI Drug Development Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe AI Drug Development Market Size by Country (2020-2025)
7.4 Europe AI Drug Development Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific AI Drug Development Market Size (2020-2031)
8.2 Asia-Pacific AI Drug Development Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific AI Drug Development Market Size by Region (2020-2025)
8.4 Asia-Pacific AI Drug Development Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America AI Drug Development Market Size (2020-2031)
9.2 Latin America AI Drug Development Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America AI Drug Development Market Size by Country (2020-2025)
9.4 Latin America AI Drug Development Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AI Drug Development Market Size (2020-2031)
10.2 Middle East & Africa AI Drug Development Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa AI Drug Development Market Size by Country (2020-2025)
10.4 Middle East & Africa AI Drug Development Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Insilico Medicine
11.1.1 Insilico Medicine Company Details
11.1.2 Insilico Medicine Business Overview
11.1.3 Insilico Medicine AI Drug Development Introduction
11.1.4 Insilico Medicine Revenue in AI Drug Development Business (2020-2025)
11.1.5 Insilico Medicine Recent Development
11.2 Cyclica
11.2.1 Cyclica Company Details
11.2.2 Cyclica Business Overview
11.2.3 Cyclica AI Drug Development Introduction
11.2.4 Cyclica Revenue in AI Drug Development Business (2020-2025)
11.2.5 Cyclica Recent Development
11.3 XtalPi Inc.
11.3.1 XtalPi Inc. Company Details
11.3.2 XtalPi Inc. Business Overview
11.3.3 XtalPi Inc. AI Drug Development Introduction
11.3.4 XtalPi Inc. Revenue in AI Drug Development Business (2020-2025)
11.3.5 XtalPi Inc. Recent Development
11.4 Exscientia Limited
11.4.1 Exscientia Limited Company Details
11.4.2 Exscientia Limited Business Overview
11.4.3 Exscientia Limited AI Drug Development Introduction
11.4.4 Exscientia Limited Revenue in AI Drug Development Business (2020-2025)
11.4.5 Exscientia Limited Recent Development
11.5 AiCure, LLC
11.5.1 AiCure, LLC Company Details
11.5.2 AiCure, LLC Business Overview
11.5.3 AiCure, LLC AI Drug Development Introduction
11.5.4 AiCure, LLC Revenue in AI Drug Development Business (2020-2025)
11.5.5 AiCure, LLC Recent Development
11.6 Atomwise
11.6.1 Atomwise Company Details
11.6.2 Atomwise Business Overview
11.6.3 Atomwise AI Drug Development Introduction
11.6.4 Atomwise Revenue in AI Drug Development Business (2020-2025)
11.6.5 Atomwise Recent Development
11.7 Biovista Inc.
11.7.1 Biovista Inc. Company Details
11.7.2 Biovista Inc. Business Overview
11.7.3 Biovista Inc. AI Drug Development Introduction
11.7.4 Biovista Inc. Revenue in AI Drug Development Business (2020-2025)
11.7.5 Biovista Inc. Recent Development
11.8 Breg,Inc.
11.8.1 Breg,Inc. Company Details
11.8.2 Breg,Inc. Business Overview
11.8.3 Breg,Inc. AI Drug Development Introduction
11.8.4 Breg,Inc. Revenue in AI Drug Development Business (2020-2025)
11.8.5 Breg,Inc. Recent Development
11.9 Numerate
11.9.1 Numerate Company Details
11.9.2 Numerate Business Overview
11.9.3 Numerate AI Drug Development Introduction
11.9.4 Numerate Revenue in AI Drug Development Business (2020-2025)
11.9.5 Numerate Recent Development
11.10 Cloud Pharmaceuticals
11.10.1 Cloud Pharmaceuticals Company Details
11.10.2 Cloud Pharmaceuticals Business Overview
11.10.3 Cloud Pharmaceuticals AI Drug Development Introduction
11.10.4 Cloud Pharmaceuticals Revenue in AI Drug Development Business (2020-2025)
11.10.5 Cloud Pharmaceuticals Recent Development
11.11 IBM
11.11.1 IBM Company Details
11.11.2 IBM Business Overview
11.11.3 IBM AI Drug Development Introduction
11.11.4 IBM Revenue in AI Drug Development Business (2020-2025)
11.11.5 IBM Recent Development
11.12 NuMedii
11.12.1 NuMedii Company Details
11.12.2 NuMedii Business Overview
11.12.3 NuMedii AI Drug Development Introduction
11.12.4 NuMedii Revenue in AI Drug Development Business (2020-2025)
11.12.5 NuMedii Recent Development
11.13 BenevolentAI
11.13.1 BenevolentAI Company Details
11.13.2 BenevolentAI Business Overview
11.13.3 BenevolentAI AI Drug Development Introduction
11.13.4 BenevolentAI Revenue in AI Drug Development Business (2020-2025)
11.13.5 BenevolentAI Recent Development
11.14 Lam Therapeutics
11.14.1 Lam Therapeutics Company Details
11.14.2 Lam Therapeutics Business Overview
11.14.3 Lam Therapeutics AI Drug Development Introduction
11.14.4 Lam Therapeutics Revenue in AI Drug Development Business (2020-2025)
11.14.5 Lam Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global AI Drug Development Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Drug Design
 Table 3. Key Players of Drug Synthesis
 Table 4. Key Players of Other
 Table 5. Global AI Drug Development Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global AI Drug Development Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global AI Drug Development Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global AI Drug Development Market Share by Region (2020-2025)
 Table 9. Global AI Drug Development Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global AI Drug Development Market Share by Region (2026-2031)
 Table 11. AI Drug Development Market Trends
 Table 12. AI Drug Development Market Drivers
 Table 13. AI Drug Development Market Challenges
 Table 14. AI Drug Development Market Restraints
 Table 15. Global AI Drug Development Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global AI Drug Development Market Share by Players (2020-2025)
 Table 17. Global Top AI Drug Development Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI Drug Development as of 2024)
 Table 18. Ranking of Global Top AI Drug Development Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by AI Drug Development Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of AI Drug Development, Headquarters and Area Served
 Table 21. Global Key Players of AI Drug Development, Product and Application
 Table 22. Global Key Players of AI Drug Development, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global AI Drug Development Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global AI Drug Development Revenue Market Share by Type (2020-2025)
 Table 26. Global AI Drug Development Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global AI Drug Development Revenue Market Share by Type (2026-2031)
 Table 28. Global AI Drug Development Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global AI Drug Development Revenue Market Share by Application (2020-2025)
 Table 30. Global AI Drug Development Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global AI Drug Development Revenue Market Share by Application (2026-2031)
 Table 32. North America AI Drug Development Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America AI Drug Development Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America AI Drug Development Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe AI Drug Development Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe AI Drug Development Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe AI Drug Development Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific AI Drug Development Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific AI Drug Development Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific AI Drug Development Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America AI Drug Development Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America AI Drug Development Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America AI Drug Development Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa AI Drug Development Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa AI Drug Development Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa AI Drug Development Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Insilico Medicine Company Details
 Table 48. Insilico Medicine Business Overview
 Table 49. Insilico Medicine AI Drug Development Product
 Table 50. Insilico Medicine Revenue in AI Drug Development Business (2020-2025) & (US$ Million)
 Table 51. Insilico Medicine Recent Development
 Table 52. Cyclica Company Details
 Table 53. Cyclica Business Overview
 Table 54. Cyclica AI Drug Development Product
 Table 55. Cyclica Revenue in AI Drug Development Business (2020-2025) & (US$ Million)
 Table 56. Cyclica Recent Development
 Table 57. XtalPi Inc. Company Details
 Table 58. XtalPi Inc. Business Overview
 Table 59. XtalPi Inc. AI Drug Development Product
 Table 60. XtalPi Inc. Revenue in AI Drug Development Business (2020-2025) & (US$ Million)
 Table 61. XtalPi Inc. Recent Development
 Table 62. Exscientia Limited Company Details
 Table 63. Exscientia Limited Business Overview
 Table 64. Exscientia Limited AI Drug Development Product
 Table 65. Exscientia Limited Revenue in AI Drug Development Business (2020-2025) & (US$ Million)
 Table 66. Exscientia Limited Recent Development
 Table 67. AiCure, LLC Company Details
 Table 68. AiCure, LLC Business Overview
 Table 69. AiCure, LLC AI Drug Development Product
 Table 70. AiCure, LLC Revenue in AI Drug Development Business (2020-2025) & (US$ Million)
 Table 71. AiCure, LLC Recent Development
 Table 72. Atomwise Company Details
 Table 73. Atomwise Business Overview
 Table 74. Atomwise AI Drug Development Product
 Table 75. Atomwise Revenue in AI Drug Development Business (2020-2025) & (US$ Million)
 Table 76. Atomwise Recent Development
 Table 77. Biovista Inc. Company Details
 Table 78. Biovista Inc. Business Overview
 Table 79. Biovista Inc. AI Drug Development Product
 Table 80. Biovista Inc. Revenue in AI Drug Development Business (2020-2025) & (US$ Million)
 Table 81. Biovista Inc. Recent Development
 Table 82. Breg,Inc. Company Details
 Table 83. Breg,Inc. Business Overview
 Table 84. Breg,Inc. AI Drug Development Product
 Table 85. Breg,Inc. Revenue in AI Drug Development Business (2020-2025) & (US$ Million)
 Table 86. Breg,Inc. Recent Development
 Table 87. Numerate Company Details
 Table 88. Numerate Business Overview
 Table 89. Numerate AI Drug Development Product
 Table 90. Numerate Revenue in AI Drug Development Business (2020-2025) & (US$ Million)
 Table 91. Numerate Recent Development
 Table 92. Cloud Pharmaceuticals Company Details
 Table 93. Cloud Pharmaceuticals Business Overview
 Table 94. Cloud Pharmaceuticals AI Drug Development Product
 Table 95. Cloud Pharmaceuticals Revenue in AI Drug Development Business (2020-2025) & (US$ Million)
 Table 96. Cloud Pharmaceuticals Recent Development
 Table 97. IBM Company Details
 Table 98. IBM Business Overview
 Table 99. IBM AI Drug Development Product
 Table 100. IBM Revenue in AI Drug Development Business (2020-2025) & (US$ Million)
 Table 101. IBM Recent Development
 Table 102. NuMedii Company Details
 Table 103. NuMedii Business Overview
 Table 104. NuMedii AI Drug Development Product
 Table 105. NuMedii Revenue in AI Drug Development Business (2020-2025) & (US$ Million)
 Table 106. NuMedii Recent Development
 Table 107. BenevolentAI Company Details
 Table 108. BenevolentAI Business Overview
 Table 109. BenevolentAI AI Drug Development Product
 Table 110. BenevolentAI Revenue in AI Drug Development Business (2020-2025) & (US$ Million)
 Table 111. BenevolentAI Recent Development
 Table 112. Lam Therapeutics Company Details
 Table 113. Lam Therapeutics Business Overview
 Table 114. Lam Therapeutics AI Drug Development Product
 Table 115. Lam Therapeutics Revenue in AI Drug Development Business (2020-2025) & (US$ Million)
 Table 116. Lam Therapeutics Recent Development
 Table 117. Research Programs/Design for This Report
 Table 118. Key Data Information from Secondary Sources
 Table 119. Key Data Information from Primary Sources
 Table 120. Authors List of This Report


List of Figures
 Figure 1. AI Drug Development Picture
 Figure 2. Global AI Drug Development Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global AI Drug Development Market Share by Type: 2024 VS 2031
 Figure 4. Drug Design Features
 Figure 5. Drug Synthesis Features
 Figure 6. Other Features
 Figure 7. Global AI Drug Development Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global AI Drug Development Market Share by Application: 2024 VS 2031
 Figure 9. Tumor Case Studies
 Figure 10. Nervous System Case Studies
 Figure 11. Other Case Studies
 Figure 12. AI Drug Development Report Years Considered
 Figure 13. Global AI Drug Development Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global AI Drug Development Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global AI Drug Development Market Share by Region: 2024 VS 2031
 Figure 16. Global AI Drug Development Market Share by Players in 2024
 Figure 17. Global Top AI Drug Development Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI Drug Development as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by AI Drug Development Revenue in 2024
 Figure 19. North America AI Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America AI Drug Development Market Share by Country (2020-2031)
 Figure 21. United States AI Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada AI Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe AI Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe AI Drug Development Market Share by Country (2020-2031)
 Figure 25. Germany AI Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France AI Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. AI Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy AI Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia AI Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries AI Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific AI Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific AI Drug Development Market Share by Region (2020-2031)
 Figure 33. China AI Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan AI Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea AI Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia AI Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India AI Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia AI Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America AI Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America AI Drug Development Market Share by Country (2020-2031)
 Figure 41. Mexico AI Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil AI Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa AI Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa AI Drug Development Market Share by Country (2020-2031)
 Figure 45. Turkey AI Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia AI Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE AI Drug Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Insilico Medicine Revenue Growth Rate in AI Drug Development Business (2020-2025)
 Figure 49. Cyclica Revenue Growth Rate in AI Drug Development Business (2020-2025)
 Figure 50. XtalPi Inc. Revenue Growth Rate in AI Drug Development Business (2020-2025)
 Figure 51. Exscientia Limited Revenue Growth Rate in AI Drug Development Business (2020-2025)
 Figure 52. AiCure, LLC Revenue Growth Rate in AI Drug Development Business (2020-2025)
 Figure 53. Atomwise Revenue Growth Rate in AI Drug Development Business (2020-2025)
 Figure 54. Biovista Inc. Revenue Growth Rate in AI Drug Development Business (2020-2025)
 Figure 55. Breg,Inc. Revenue Growth Rate in AI Drug Development Business (2020-2025)
 Figure 56. Numerate Revenue Growth Rate in AI Drug Development Business (2020-2025)
 Figure 57. Cloud Pharmaceuticals Revenue Growth Rate in AI Drug Development Business (2020-2025)
 Figure 58. IBM Revenue Growth Rate in AI Drug Development Business (2020-2025)
 Figure 59. NuMedii Revenue Growth Rate in AI Drug Development Business (2020-2025)
 Figure 60. BenevolentAI Revenue Growth Rate in AI Drug Development Business (2020-2025)
 Figure 61. Lam Therapeutics Revenue Growth Rate in AI Drug Development Business (2020-2025)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart